Cargando…

Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood

Introduction: Hemolytic-uremic syndrome (HUS) is a common cause for intrarenal acute kidney injury in childhood. More than 90% of HUS cases are associated with an infection by Shigatoxin-producing Escherichia coli (STEC) whereas the reminder comprises a heterogeneous group (here classified as Non-ST...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaterodt, Laura, Holle, Johannes, Hüseman, Dieter, Müller, Dominik, Thumfart, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090047/
https://www.ncbi.nlm.nih.gov/pubmed/30131950
http://dx.doi.org/10.3389/fped.2018.00220
_version_ 1783347130052640768
author Vaterodt, Laura
Holle, Johannes
Hüseman, Dieter
Müller, Dominik
Thumfart, Julia
author_facet Vaterodt, Laura
Holle, Johannes
Hüseman, Dieter
Müller, Dominik
Thumfart, Julia
author_sort Vaterodt, Laura
collection PubMed
description Introduction: Hemolytic-uremic syndrome (HUS) is a common cause for intrarenal acute kidney injury in childhood. More than 90% of HUS cases are associated with an infection by Shigatoxin-producing Escherichia coli (STEC) whereas the reminder comprises a heterogeneous group (here classified as Non-STEC-HUS). Renal impairment can persist in patients with HUS. This study presents data from four decades investigating the short- and long-term outcome of HUS in childhood. Materials and Methods: In a retrospective single-center-study clinical and laboratory data of the acute phase and of 1- to 10-year follow-up visits of children with HUS were analyzed. Results: 92 HUS-patients were identified from 1996 to 2014 (STEC-HUS-group: n = 76; Non-STEC-HUS-group: n = 16) and 220 HUS-patients between 1976 and 1995. STEC-HUS was increasingly caused by Non-O157 strains and mortality rate declined over the past decades (1.3 vs. 9.5%). Renal sequelae persisted more often in the group 1976–1995 (39.3%) than in the group 1996–2014 (28.3%), but more than 50% of all patients were lost to follow-up. Conclusion: Although renal outcome has improved over the investigated last decades, patients with HUS still face a high risk of permanent renal damage. These findings underline the importance of a consequent long-term follow-up in HUS-patients.
format Online
Article
Text
id pubmed-6090047
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60900472018-08-21 Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood Vaterodt, Laura Holle, Johannes Hüseman, Dieter Müller, Dominik Thumfart, Julia Front Pediatr Pediatrics Introduction: Hemolytic-uremic syndrome (HUS) is a common cause for intrarenal acute kidney injury in childhood. More than 90% of HUS cases are associated with an infection by Shigatoxin-producing Escherichia coli (STEC) whereas the reminder comprises a heterogeneous group (here classified as Non-STEC-HUS). Renal impairment can persist in patients with HUS. This study presents data from four decades investigating the short- and long-term outcome of HUS in childhood. Materials and Methods: In a retrospective single-center-study clinical and laboratory data of the acute phase and of 1- to 10-year follow-up visits of children with HUS were analyzed. Results: 92 HUS-patients were identified from 1996 to 2014 (STEC-HUS-group: n = 76; Non-STEC-HUS-group: n = 16) and 220 HUS-patients between 1976 and 1995. STEC-HUS was increasingly caused by Non-O157 strains and mortality rate declined over the past decades (1.3 vs. 9.5%). Renal sequelae persisted more often in the group 1976–1995 (39.3%) than in the group 1996–2014 (28.3%), but more than 50% of all patients were lost to follow-up. Conclusion: Although renal outcome has improved over the investigated last decades, patients with HUS still face a high risk of permanent renal damage. These findings underline the importance of a consequent long-term follow-up in HUS-patients. Frontiers Media S.A. 2018-08-07 /pmc/articles/PMC6090047/ /pubmed/30131950 http://dx.doi.org/10.3389/fped.2018.00220 Text en Copyright © 2018 Vaterodt, Holle, Hüseman, Müller and Thumfart. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Vaterodt, Laura
Holle, Johannes
Hüseman, Dieter
Müller, Dominik
Thumfart, Julia
Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title_full Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title_fullStr Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title_full_unstemmed Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title_short Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
title_sort short- and long-term renal outcome of hemolytic-uremic syndrome in childhood
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090047/
https://www.ncbi.nlm.nih.gov/pubmed/30131950
http://dx.doi.org/10.3389/fped.2018.00220
work_keys_str_mv AT vaterodtlaura shortandlongtermrenaloutcomeofhemolyticuremicsyndromeinchildhood
AT hollejohannes shortandlongtermrenaloutcomeofhemolyticuremicsyndromeinchildhood
AT husemandieter shortandlongtermrenaloutcomeofhemolyticuremicsyndromeinchildhood
AT mullerdominik shortandlongtermrenaloutcomeofhemolyticuremicsyndromeinchildhood
AT thumfartjulia shortandlongtermrenaloutcomeofhemolyticuremicsyndromeinchildhood